These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9046903)

  • 41. [A patient with Prader-Willi syndrome. Characteristics, oral consequences and treatment options].
    Bots CP; Schueler YT; Brand HS; van Nieuw Amerongen A
    Ned Tijdschr Tandheelkd; 2004 Feb; 111(2):55-8. PubMed ID: 15024795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The foot in Prader-Willi syndrome: a case report.
    Sánchez-Rodríguez R; Martínez-Nova A; Escamilla-Martínez E; Gómez-Martín B
    J Paediatr Child Health; 2009 Apr; 45(4):237-8. PubMed ID: 19426385
    [No Abstract]   [Full Text] [Related]  

  • 43. Foreign body aspiration in a boy with Prader-Willi Syndrome.
    Jacob SS; Jacob JJ; Paul TV
    Singapore Med J; 2008 Jan; 49(1):e12-4. PubMed ID: 18204752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Focal segmental glomerulosclerosis in a patient with Prader-Willi syndrome.
    Mochizuki H; Joh K; Matsuyama N; Imadachi A; Usui N; Eto Y
    Clin Nephrol; 2000 Mar; 53(3):212-5. PubMed ID: 10749301
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A case of Prader-Willi syndrome with tubular acidosis and partial ocular albinism].
    Parcheta B; Piontek E; Zawadzki J; Ryzko J
    Wiad Lek; 1987 May; 40(10):694-8. PubMed ID: 3673078
    [No Abstract]   [Full Text] [Related]  

  • 46. Growth hormone induced lipolysis during short- and long-term administration in adult Prader-Willi patients.
    Höybye C; Hilding A; Marcus C; Thorén M
    Growth Horm IGF Res; 2005 Dec; 15(6):411-5. PubMed ID: 16230042
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Prader-Willi syndrome].
    Mochizuki H; Usui N
    Ryoikibetsu Shokogun Shirizu; 1997; (17 Pt 2):494-6. PubMed ID: 9277975
    [No Abstract]   [Full Text] [Related]  

  • 48. Weight control in obese diabetics. A comparative trial of Filon and phenmetrazine.
    Buckle RM; Silverstone JT
    Br J Clin Pract; 1966 Jul; 20(7):363-5. PubMed ID: 5940969
    [No Abstract]   [Full Text] [Related]  

  • 49. Prader-Willi syndrome: atypical psychoses and motor dysfunctions.
    Verhoeven WM; Tuinier S
    Int Rev Neurobiol; 2006; 72():119-30. PubMed ID: 16697294
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of an anorectic agent, AN 448 on weight reduction and plasma lipids.
    Ishikawa T; Nakaya N; Nakamura H; Goto Y
    Keio J Med; 1975 Jul; 24(3):211-8. PubMed ID: 1219154
    [No Abstract]   [Full Text] [Related]  

  • 51. Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients.
    Lucchetta RC; Riveros BS; Pontarolo R; Radominski RB; Otuki MF; Fernandez-Llimos F; Correr CJ
    Clinics (Sao Paulo); 2017 May; 72(5):317-324. PubMed ID: 28591345
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Obesity and diabetes mellitus].
    Vasiukova EA; Granovskaia-Tsvetkova AM
    Klin Med (Mosk); 1979 Jan; 57(1):70-6. PubMed ID: 439804
    [No Abstract]   [Full Text] [Related]  

  • 53. Type I diabetes mellitus, ketoacidosis and thromboembolism in an adolescent with Prader-Willi syndrome.
    Anhalt H; Eckert KH; Hintz RL; Neely EK
    Acta Paediatr; 1996 Apr; 85(4):516. PubMed ID: 8740319
    [No Abstract]   [Full Text] [Related]  

  • 54. Prader-Willi syndrome associated with dilated cardiomyopathy.
    Takaya J; Higashino H; Tsujimoto D; Hata Y; Kaneko K
    Pediatr Int; 2010 Jun; 52(3):503-4. PubMed ID: 20723130
    [No Abstract]   [Full Text] [Related]  

  • 55. Prader--Willi--Syndrome.
    Babel CS; Andrew AM; Goyal VK; Bhu N; Agarwal GR
    J Assoc Physicians India; 1982 Nov; 30(11):848-50. PubMed ID: 7185831
    [No Abstract]   [Full Text] [Related]  

  • 56. [Use of dezopimon in the treatment of patients with diabetes mellitus and obesity].
    Kliachko VR; Tirkina TN; Perelygina AA
    Probl Endokrinol (Mosk); 1970; 16(4):20-3. PubMed ID: 5517109
    [No Abstract]   [Full Text] [Related]  

  • 57. Letter: Drugs in obesity.
    Jackson WP; Vinik AI
    S Afr Med J; 1975 May; 49(20):803. PubMed ID: 1098170
    [No Abstract]   [Full Text] [Related]  

  • 58. [Hereditary syndrome associated with diabetes mellitus].
    Ohta Y; Tanizawa Y
    Nihon Rinsho; 2012 Jul; 70 Suppl 5():205-10. PubMed ID: 23156395
    [No Abstract]   [Full Text] [Related]  

  • 59. [Clinical use of mazindol in the treatment of essential obesity].
    Guazzelli R; Piazzini M; Conti C; Papi L; Strazzulla G; Matassi L
    Clin Ter; 1987 Mar; 120(5):385-91. PubMed ID: 2953538
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of naloxone on hyperphagia in Prader-Willi syndrome.
    Kyriakides M; Silverstone T; Jeffcoate W; Laurance B
    Lancet; 1980 Apr; 1(8173):876-7. PubMed ID: 6103230
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.